The global demand for Anastrozole Tablets Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026. Whereas with regards to volume, the market was calculated XX Kilo Tons in 2019 and foreseen to touch XX Kilo Tons by 2026 with a CAGR of XX% during 2020-2026.
Anastrozole tablets are hormonal therapy medicine, chemically described as 1,3-Benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl). This tablet is prescribed to treat breast cancer in women after menopause. The tablet works by decreasing the amount of estrogen the body makes and helps to slow or inhibit the growth of breast cancer. It is available as a generic drug and as a brand-name drug: Arimidex.
The global burden of breast cancer will increase to over 2 million new cases per year by 2030. Breast cancer is the most prevelanat female cancer globally. Risk of developing breast cancer increases as a woman ages or reaches a menopause stage. This will drive the demand for anastrozole tablets. Anastrozole tablet is under development or clinical trial for other treatments such as gynecomastia, female infertility, endometriosis, and hypogonadism. Favorable results from the trial will present an opportunity for the market. However, there are concerns about its side effect such as constipation, diarrhea, vomiting, upset stomach, among others which is hampering the growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of anastrozole tablets.
The entire anastrozole tablets market has been sub-categorized into type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Distribution Channel
- Branded Anastrozole Tablets
- Generic Anastrozole Tablets
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This section covers regional segmentation which accentuates on current and future demand for anastrozole tablets market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Anastrozole Tablets Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the anastrozole tablets market include AstraZeneca Plc, Zydus Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Natco Pharma. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.